期刊文献+

DWI联合DCEMRI对乳腺非肿块样强化病灶的诊断价值 被引量:6

DWI combined with DCE MRI for differential diagnosis between benign and malignant diseases in breast lesions with MRI none-mass enhancement
下载PDF
导出
摘要 目的探讨弥散加权成像(diffusion-weighted MR imaging,DWI)联合动态对比增强磁共振成像(dynamic contrast-enhanced M R imaging,DCE M RI)对表现为非肿块样强化(none-mass enhancement,NM LE)的乳腺良恶性病变的诊断价值。方法回顾性分析49个乳腺NMLE病灶,比较良恶性组间强化分布、内部强化特征、动态曲线模式及表观弥散系数(apparent diffusion coefficient,ADC)值的差异有无统计学意义。绘制接受者操作特征曲线(receiver operating characteristic curve,ROC)评估ADC值的诊断效能、确定最佳诊断分界点。应用多因素分析探讨表现为NMLE的乳腺恶性病变的磁共振影像特征。结果良恶性组间病灶的内部强化特征、动态曲线模式的差异无统计学意义(P>0.05)。段样分布(P=0.01)、病灶内ADC值<1.2×10-3mm2/s(P<0.001)提示其为乳腺癌。段样分布的诊断灵敏度(sensitivity,Se)、特异度(specificity,Sp)、阳性预测值(positive predictive value,PPV)、阴性预测值(negative predictive value,NPV)分别为73.1%、87.0%、86.4%、74.1%。以ADC阈值为诊断标准,其Se、Sp、PPV、NPV分别为:84.6%、91.3%、91.7%、84.0%。当NMLE表现为段样分布且病灶内ADC值小于1.2×10-3mm2/s时强烈提示其为乳腺癌,PPV为92.9%。结论 DWI联合DCE M RI对于表现为NM LE的乳腺癌具有较高的诊断准确性。 Objective To evaluation the application of a combination of diffusion-weighted imaging( DWI) and dynamic contrast-enhanced MR imaging( DCEMR I) in differentiating benign from malignant lesions showing non-mass-liked enhancement( NMLE) on breast MR imaging.Methods MRI findings of 49 breast lesions showing NMLE were retrospectively reviewed. The distribution,internal enhancement,kinetic curve pattern and minimal apparent diffusion coefficient( ADC) values were analyzed. The threshold of ADC for differentiating lesions was determined with receiver operating characteristic( ROC) analysis. The indicators for malignancy were determined with multivariate analysis. Results There was no significant difference in internal enhancement and kinetic curve pattern between benign and malignant lesions. Segmental distribution( P〈 0. 001) and ADC value 1. 2 × 10^- 3mm2/ s were the MR indicators of malignancy. When lesions showsegmental distribution,the sensitivity,specificity,negative predictive value( NPV) and positive predictive value( PPV) were 73. 1%,87. 0%,86. 4% and 74. 1%,respectively. The ADC threshold yielded sensitivity( 84. 6%), specificity( 91. 3%), NPV( 91. 7%) and PPV( 84. 0%). The segmental distribution of NMLE lesion with ADC value 1. 2 × 10^- 3mm2/ s strongly indicated the malignancy,with a PPV of 92. 9%. Conclusion The combination of diffusion-weighted imaging and dynamic contrast-enhanced MR imaging shows high diagnostic accuracy for breast NMLE lesions.
出处 《同济大学学报(医学版)》 CAS 2015年第1期67-71,共5页 Journal of Tongji University(Medical Science)
关键词 乳腺磁共振成像 动态增强MRI 非肿块样强化 扩散加权 表观弥散系数 breast MRI dynamic contrast-enhanced MR images none-mass-like enhancement diffusion weighted MR images apparent diffusion coefficient
  • 相关文献

参考文献10

  • 1张敏璐,黄哲宙,郑莹.中国2008年女性乳腺癌发病、死亡和患病情况的估计及预测[J].中华流行病学杂志,2012,33(10):1049-1051. 被引量:179
  • 2Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast- enhanced and diffusion-weighted MR images[J]. J Magn Reson Imaging, 2008,28 ( 5 ) : 1157 -1165.
  • 3Tozaki M, Fukuda IC High-spatial-resolution MRI of non-mass like breast lesions : interpretation model based on BI-RADS MRI descriptors [ J ]. AJR Am J Roentgenol, 2006,187 ( 2 ) : 330 - 337.
  • 4Baltzer PA, Benndorf M, Dietzel M, et al. False- positive findings at contrast-enhanced breast MR/: a BI-RADS descriptor study[J]. AJR Am J Roentgenol, 2010,194(6) : 1658 - 1663.
  • 5Ballesio L, Di Pastena F, Gigli S, et al. Non mass- like enhancement categories detected by breast MRI and histological findings [ J ]. Eur Rev Med Pharmacol Sci, 2014,18(6) : 910 -917.
  • 6许玲辉,彭卫军,顾雅佳,李瑞敏,刘晓航,汪晓红,毛健,唐峰,丁建辉.乳腺导管原位癌的MRI表现[J].中华放射学杂志,2011,45(2):159-163. 被引量:47
  • 7Imamura T, Isomoto I, Sueyoshi E, et al. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging [ J]. Magn Reson Med Sci, 2010,9 (4) : 217 -225.
  • 8Sakamoto N, Tozaki M, Higa K, et al. Categorization of non-mass-like breast lesions detected by MRI [J].Breast Cancer, 2008,15 (3) : 241 - 246.
  • 9赵斌,蔡世峰,高佩虹,彭洪娟.MR扩散加权成像鉴别乳腺良恶性病变的研究[J].中华放射学杂志,2005,39(5):497-500. 被引量:146
  • 10Yabuuchi H, Matsuo Y, Kamitani T, et al. Non-mass- like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images[J]. Eur J Radiol, 75(1) : e126 -e132.

二级参考文献40

  • 1刘溢,谢敬霞,韩鸿宾,杨渝平,刘淳.磁共振扩散加权成像在乳腺肿瘤的初步应用[J].中国医学影像技术,2003,19(5):548-551. 被引量:38
  • 2全国肿瘤防治研究办公室,卫生部卫生信息中心.中国试点市、县恶性肿瘤的发病与死亡(1993-1997).北京:中国医药科技出版社,2002.
  • 3Schuh ME,Nemoto T,Penetrante RB,et al.Intraductal carcinoma:analysis of presentation,pathologic findings,and outcome of disease.Arch Surg,1986,121:1303-1307.
  • 4American College of Radiology (ACR).Breast imaging reporting and data system (BI-RADS).4th ed,Reston:American College of Radiology.2003:1-259.
  • 5Morakkabati-Spitz N,Leutner C,Schild H,et al.Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI.Eur Radiol,2005,15:2010-2017.
  • 6Van Goethem M,Schelfout K,Kersschot E,et al.Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast JBR-BTR,2005,88:225-232.
  • 7Viehwng P,Lampe D,Buchmann J,et al.In situ and minimally invasive breast cancer:morphologic and kinetic features of contrast enhanced MR imaging.MAGMA,2000,11:129-137.
  • 8Lee CH.Problem solving MR imaging of the breast.Radiol Clin North Am,2004,42:919-934.
  • 9Facius M,Renz DM,Neubauer H,et al.Characteristics of ductal carcinoma in situ in magnetic resonance imaging.Clin Imaging,2007,31:394-400.
  • 10Tozaki M,Fukuda K.High-spatial-resolution MRI of non-masslike breast lesions:interpretation model based on BI-RADS MRI descriptors.AJR,2006,187:330-337.

共引文献368

同被引文献62

  • 1Leonard GD,Swain SM. Ductal carcinoma in situ: Com- plexities and challenges[J]. J Natl Cancer Inst,2004,96(12) : 906-920.
  • 2Jvirnig BA, Tuttle TM, Shamliyan T, et al. Ductal carci- noma in situ of the breast:A systematic review of Inci- dence,treatment,and outcomes[J]. Natl Cancer Inst,2010, 102(3) : 170-178.
  • 3Jadamovich TL,Simmons RM. Ductal carcinoma in situ with microinvastion[J]. Am J Surg, 2003,186 (2) : 112-116.
  • 4Hungermann D, Decker T,Btirger H, et al. Papillary tumors of the breast[J]. Pathologe, 2006,27 (5) : 350-357.
  • 5Facius M,Renz DM,Neubauer H,et al. Characteristics of ductal carcinoma in situ in magnetic resonance imaging[J]. Clin Imaging, 2007,31 (6) : 394-400.
  • 6Yamada T, Mori N,Watanabe M, et al. Radiologic patho-logic correlation of ductal carcinoma in situ[J]. Radiograph- ics, 2010,30(5) : 1183-1198.
  • 7Westerhof JP,Fischer U,Moritz JD,et al. MR imaging of mammographically detected clustered microcalcificatious: Is there any value? [J]. Radiology, 1998,207(5) :675-681.
  • 8Kuhl CK. Why do purely intraductal cancers enhance on breast MR images[J]. Radiology, 2009,253(2) : 281-283.
  • 9Sinha S,Lucas Quesada FA,Sinha U,et al. In vivo dif- fusion weighted MRI of the breast:Potential for lesion eharacterization[J]. J Magn Reson Imaging, 2002,15 (6) : 693-704.
  • 10Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagno- sis of pure ductal carcinoma in situ:A prospective obser- vational study[J]. Lancet, 2007,370(9586) : 485-492.

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部